IMMX · Immix Biopharma, Inc.
$8.44
-0.25 (-2.88%)
At close · Jul 28
Going-concern doubt
— flagged May 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts of liabilities that may result from uncertainty related to the Company’s ability to continue as a going concern.”View the 10-Q filed May 7, 2026
Market Cap
$459.23M
Shares
54.41M
Positioning
Aug 21, 2026 · 23 days to expiry · 18 contractsPut / call OI
1.52
Put-heavy positioning
Open interest
3,837
contracts outstanding
Volume
590
traded today
Max pain
$10.00
$1.56 above spot
ATM implied vol
117%
market's expected move
Open interest by strike
Calls
Puts
2.5
5
7.5
10
12.5
15
17.5
20
22.5
Chain
Click any strike for greeks, breakeven and the calculator| Calls | Puts | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| OI | Vol | IV | Δ | Last | Strike | Last | Δ | IV | Vol | OI |
| 1 | 2 | — | — | $6.45 | $0.05 | — | — | 60 | 2 | |
| 85 | 10 | 222.8% | 0.882 | $5.90 | $0.05 | -0.109 | 207.5% | 20 | 64 | |
| 118 | 109 | 130.6% | 0.685 | $1.42 | $0.50 | -0.299 | 103.3% | 281 | 1.1k | |
| 867 | 1 | 120.9% | 0.328 | $1.00 | $1.65 | — | — | 100 | 1.2k | |
| 426 | 3 | 256.1% | 0.382 | $0.40 | $3.78 | — | — | 1 | 7 | |
| 14 | 1 | 216.6% | 0.208 | $0.55 | — | — | — | — | 0 | |
| 10 | 1 | 323.5% | 0.312 | $1.00 | — | — | — | — | 0 | |
| 2 | 1 | 418% | 0.384 | $0.15 | — | — | — | — | 0 | |
| 0 | — | — | — | — | — | — | — | — | 0 | |
About this data
Greeks, implied volatility, open interest and the last price come from the latest daily snapshot and are 15-minute delayed. Bid and ask are not included on this plan.
In-the-money strikes are tinted, deepening toward the money, and the bar beside each open-interest figure scales to the heaviest strike shown. Max pain is the listed strike where the most open interest would expire worthless — a positioning reference, not a forecast.